Neuroprotective role of carbon monoxide release from cell-free pegylated hemoglobin during repurfusion from transient focal cerebral ischemia by Prolong Pharma | Jan 1, 2017 | Conferences
Pegylated Carboxyhemoglobin (SanguinateTM): A Potential Immunomodulatory Drug For Targeting Cystic Fibrosis by Prolong Pharma | Jan 1, 2017 | Conferences
Hemoglobin-based blood substitutes and the treatment of sickle cell disease: More harm than help? by Prolong Pharma | Jan 1, 2017 | Publications